key: cord-0958285-58s5rfub
authors: Chen, Liting; Long, Xiaolu; Xu, Qian; Tan, Jiaqi; Wang, Gaoxiang; Cao, Yang; Wei, Jia; Luo, Hui; Zhu, Hui; Huang, Liang; Meng, Fankai; Huang, Lifang; Wang, Na; Zhou, Xiaoxi; Zhao, Lei; Chen, Xing; Mao, Zekai; Chen, Caixia; Li, Zhen; Sun, Ziyong; Zhao, Jianping; Wang, Daowen; Huang, Gang; Wang, Wei; Zhou, Jianfeng
title: Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients
date: 2020-07-03
journal: Cell Mol Immunol
DOI: 10.1038/s41423-020-0492-x
sha: fee89a2e27862ad839f1bc6f6f2e3bcf43c185d6
doc_id: 958285
cord_uid: 58s5rfub

nan

COVID-19 patients treated in general wards had significantly elevated level of S100A8/A9 (P = 0.033) but not HMGB1 (P > 0.9999) as compared to healthy controls, suggesting that S100A8/A9 is a more sensitive alarmin than HMGB1 in response to SARS-CoV-2 infection. However, both S100A8/A9 and HMGB1 were significantly elevated extracellularly in ICU-admission patients compared to non-ICU patients, or in fatal outcomes patients compared to alive patients ( Fig. 1a-d) , indicating that significant elevation of S100A8/ A9 and HMGB1 was associated with high mortality.

We further examined the Spearman's correlation between the serum S100A8/A9 or HMGB1 levels and clinical manifestations in COVID-19 patients. First of all, either serum levels of S100A8/A9 or HMGB1 at admission were positively correlated with peak CT score and oxygen demand, which is indicative of the severity of acute lung injury and ARDS (Fig. 1e , f and S1a, b). Moreover, the degree of organic impairment, as evaluated by the MCP classification, NT-proBNP level, cTn I level, and AKI stage were well correlated with the serum levels of S100A8/A9 or HMGB1 (Fig. S1c-j) . The level of peak D-dimer significantly was elevated as the serum S100A8/A9 or HMGB1 increased (Fig. 1g, h) . On the other hand, the ratio of neutrophils to lymphocytes was positively correlated with the serum S100A8/A9 but not with HMGB1, suggesting S100A8/A9 plays a more important role in the substantial reduction of the peripheral lymphocytes. The serum S100A8/A9 was strongly correlated with the qSOFA score, 8 a quick indicator of sepsisrelated organ dysfunction, indicating that patients with higher S100A8/A9 or HMGB1 levels tended to suffer from more severe sepsis-related organ dysfunction (both P < 0.0001) ( Fig. 1i-l) .

We then evaluated the potential correlation between levels of S100A8/A9 or HMGB1 and COVID-GRAM risk scores. Either levels of S100A8/A9 (P < 0.0001) or HMGB1 (P = 0.030) significantly correlated with the COVID-GRAM risk scores (Fig. 1m, n) . Serum levels of S100A8/ Fig. 1 Serum levels of S100A8/A9 and HMGB1 were strongly correlated with the severity of clinical manifestations and with great predictive power for the risk for ICU admission and death. a, b Comparison of S100A8/A9 and HMGB1 levels between healthy people, non-ICU patients, and ICU patients of COVID-19. c, d Comparison of S100A8/A9 and HMGB1 levels between healthy people, alive patients and dead patients of COVID-19. Spearman's correlation analyses between S100A8/A9 or HMGB1 levels and peak CT score (e, f), D-dimer level (g, h), neutrophil/ lymphocyte ratio (i, j), and quick Sequential Organ Failure Assessment (qSOFA) scores (k, l). m, n Spearman's correlation analyses of S100A8/A9 or HMGB1 and COVID-GRAM risk score. o, p Comparison of S100A8/A9 or HMGB1 between healthy people and COVID-19 patients of different risk groups (divided according to COVID-GRAM risk score). q, r Receiver operating characteristic (ROC) curve evaluation of the performance of S100A8/A9, HMGB1, combined S100A8/A9 and HMGB1, and COVID-GRAM risk score in distinguish COVID-19 patients with ICU admission or subsequent death. Sixty days survival is shown for patients with different circulating S100A8/A9 levels (s) and different COVID-GRAM risks (t) by Kaplan-Meier curves Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are. . . L Chen et al.

A9 but not HMGB1 were significantly increased in patient with high risk of COVID-GRAM risk scores which were defined according to the online calculator (http://118.126.104.170) 4 (Fig. 1o, p) , highlighting that S100A8/A9 is a better prognostic indicator than HMGB1.

The prognostic values of S100A8/A9, HMGB1 or COVID-GRAM risk scores were further evaluated by ROC analysis and their areas under curve were calculated (Fig. 1q, r) . For the prediction of ICU admission, the AUCs for COVID-GRAM risk scores with S100A8/A9, HMGB1 and S100A8/A9 and HMGB1 in combination were 0.810, 0.860, 0.781 and 0.901, respectively (Table S2 ). For the prediction of subsequent death, the AUCs for COVID-GRAM risk scores, S100A8/A9, HMGB1 and S100A8/A9 and HMGB1 in combination were 0.818, 0.875, 0.694 and 0.881, respectively (Table S2) . The sensitivity and specificity of S100A8/A9 and HMGB1 of the ROC curves illustrated in Fig. 1q , r were listed in Table S2 . The combination of S100A8/A9 with HMGB1 increased the prediction power compared to S100A8/A9 or HMGB1 alone although no significant differences were observed statistically (Table S2) .

Moreover, higher S100A8/A9 level (P < 0.0001) or higher COVID-GRAM risk score (P < 0.0001) resulted in significant worse overall survival (Fig. 1s, t) . The COVID-19 patients were classified into low or high level groups according to the concentrations of S100A8/ A9 at a cutoff of 6195 ng/ml, which was set by maximizing Youden's index according to the ROC curves (Fig. 1s) . Meanwhile, the COVID-19 patients were also classified into high-risk or nonhigh-risk groups according to COVID-GRAM risk scores (Fig. 1t) . The hazard ratio of high S100A8/A9 level was 13.32, which was greater than that of COVID-GRAM risk score (HR = 4.612). The concentrations of S100A8/A9 measured at hospital admission showed better predictive power than COVID-GRAM risk scores for subsequent death in COVID-19 patients.

To explore the possible correlation between S100A8/A9 or HMGB1 and cytokine storm in COVID-19, the serum levels of S100A8/A9 or HMGB1 were analyzed by Spearman's correlation tests to know their correlation with of each of the 48 cytokine concentrations in individual patients (Table S3) . While the serum levels of S100A8/A9 or HMGB1 correlated with the concentrations of a different spectrum of pro-inflammatory cytokines, 12 cytokines, including IL-8, MCP-3, MCP-1, IL-1ra, β-NGF, IL-7, IL-10, RANTES, G-CSF, IL-1α, CTACK and IL-17A, simultaneously correlated with both the S100A8/A9 and HMGB1. Interestingly, 3 myeloid chemokines, IL-8, MCP-3 and MCP-1, were among the most significant cytokines simultaneously correlated with both the S100A8/A9 and HMGB1 and showed the lowest P value (P < 0.0001), indicating that the overproduced S100A8/A9 and HMGB1 in serum were associated with distinct signatures for cytokine storm in patients with COVID-19. 9, 10 In conclusion, this study identified two alarmins, especially S100A8/A9, could accurately identify patients who were subsequently admitted to ICU wards or died with a predictive precision similar to or better than COVID-GRAM risk score. Taking S100A8/ A9 as a predictor for COVID-19 might offer some advantages over other clinical or laboratory indicators, since it is easy to measure and the result is easy to interpret. As a single parameter alone, to our knowledge, S100A8/S100A9 is the only one helpful for an early identification of COVID-19 patients who may be admitted to ICU admission or facing death. Using S100A8/A9 to distinguish COVID-19 patients with fatal outcomes is of great clinical significance.

Covid-19: WHO declares pandemic because of "alarming levels" of spread, severity, and inaction

Clinical features of 85 fatal cases of COVID-19 from Wuhan. A retrospective observational study

Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis

Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19

DAMPs from cell death to new life

Immunogenic cell death and DAMPs in cancer therapy

Alarmins: awaiting a clinical response

Association of the Quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) Score With Excess Hospital Mortality in Adults With Suspected Infection in Low-and Middle-Income Countries

Inhibition of extracellular HMGB1 attenuates hyperoxia-induced inflammatory acute lung injury

The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis

We appreciate eStart Medical Technology. CO 

The online version of this article (https://doi.org/10.1038/s41423-020-0492-x) contains supplementary material.Competing interests: The authors declare no competing interests.